BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.990
+0.070 (1.42%)
At close: Mar 26, 2026
BioStem Technologies Revenue
In the year 2025, BioStem Technologies had annual revenue of $47.48M, down -84.27%. BioStem Technologies had revenue of $10.08M in the quarter ending December 31, 2025, a decrease of -90.20%.
Revenue
47.48M
Revenue Growth
-84.27%
P/S Ratio
1.77
Revenue / Employee
1.44M
Employees
33
Market Cap
84.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.48M | -254.35M | -84.27% |
| Dec 31, 2024 | 301.83M | 285.14M | 1,708.93% |
| Dec 31, 2023 | 16.69M | 9.81M | 142.69% |
| Dec 31, 2022 | 6.88M | 2.53M | 58.38% |
| Dec 31, 2021 | 4.34M | 4.03M | 1,284.88% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaxart | 237.26M |
| Nuo Therapeutics | 2.61M |
| Harvard Apparatus Regenerative Technology | 704.00K |
| Silence Therapeutics | 559.00K |
| Provectus Biopharmaceuticals | 350.44K |
| ZIVO Bioscience | 209.03K |
| Arch Biopartners | 115.29K |
BioStem Technologies News
- 2 days ago - BioStem Technologies, Inc. (BSEM) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair - GlobeNewsWire
- 2 months ago - BioStem Technologies, Inc. (BSEM) M&A Call Transcript - Seeking Alpha
- 2 months ago - BioTissue Holdings, Inc Strengthens Strategic Focus on Ocular Innovation with Sale of Surgical and Wound Care Business to BioStem Technologies - PRNewsWire
- 4 months ago - BioStem Technologies, Inc. (BSEM) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant - GlobeNewsWire
- 7 months ago - BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 8 months ago - BioStem Technologies, Inc. (BSEM) Q2 2025 Earnings Call Transcript - Seeking Alpha